DFG/ SFB1066-1
Laufzeit: 01.01.2017 - 31.12.2021
imported
Kurzfassung
“Therapy of Metastatic Melanoma by Addressing Tolerance Inducing M2-Macrophages“with therapeutic Nanoparticles”. Collaborative Research Center SFB1066/2 “Nanodimensional Therapeutics for Cancer Therapy.”